EW vs PRSO · P/E 47, rev $1.39B vs rev $14.6M
Edwards Lifesciences Corp (EW) versus Peraso Inc (PRSO) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Peraso Inc (PRSO) is a semiconductors company listed on NASDAQ.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported PRSO revenue for 2024-12-31 was $14.6M. Net income was -$10.7M. Revenue was up 6.0% from 2023-12-31 to 2024-12-31. PRSO currently screens at market cap $13.1M.
EW currently screens at market cap $49.91B and trailing P/E 46.9. PRSO currently screens at market cap $13.1M.
Not investment advice. Open the EW and PRSO stock pages for the full models.
Not investment advice.